Longevity Acquisition Corporation (LOAC) is a Business Services company listed on NASDAQ. There were no new wire items for LOAC in the last 30 days. The most recent was published Apr 7, 2021.
Latest news
25 items- SECSEC Form EFFECT filed by Longevity Acquisition CorporationEFFECT - Longevity Acquisition Corp (0001743858) (Filer)
- SECSEC Form 15-15D filed by Longevity Acquisition Corporation15-15D - Longevity Acquisition Corp (0001743858) (Filer)
- SECSEC Form POS AM filed by Longevity Acquisition CorporationPOS AM - Longevity Acquisition Corp (0001743858) (Filer)
- SECSEC Form 25-NSE filed by Longevity Acquisition Corporation25-NSE - Longevity Acquisition Corp (0001743858) (Subject)
- PR4D pharma Announces Completion of Merger With Longevity Acquisition CorporationLEEDS, England--(BUSINESS WIRE)--4D pharma plc (Nasdaq: LBPS; AIM: DDDD) ("4D pharma" or the "Company"), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome - today announced completion of its merger (“the Merger”) with Longevity Acquisition Corporation ("Longevity")(Nasdaq: LOAC). 4D pharma American Depositary Shares (“ADSs”) are expected to begin trading today on the Nasdaq Global Market under the ticker symbol ‘LBPS.’ Warrants of Longevity assumed by 4D pharma in the Merger are currently expected to begin trading on Nasdaq under the ticker symbol ‘LBPSW’ tomorrow, Tuesday, March 23, 2021. Lo
- SECSEC Form 425 filed by Longevity Acquisition Corporation425 - Longevity Acquisition Corp (0001743858) (Subject)
- SECSEC Form 8-K filed by Longevity Acquisition Corporation8-K - Longevity Acquisition Corp (0001743858) (Filer)
- SECSEC Form 425 filed by Longevity Acquisition Corporation425 - Longevity Acquisition Corp (0001743858) (Subject)
- PRLongevity Acquisition Corporation Announces Results of Special Meeting of ShareholdersNEW YORK, March 18, 2021 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today the results of its special meeting of shareholders, which was held on March 17, 2021. At the special meeting, shareholders of the Company approved the merger, including a certain agreement and plan of merger, dated as of October 21, 2020, by and among 4d pharma plc, the Company and Dolphin Merger Sub Limited, and the related agreements and transactions contemplated thereby. About LOAC LOAC is a blank check company, also commonly referred to as a Special Purpose Acquisition Company, or SPAC, formed for the purpose of
- SECSEC Form 425 filed by Longevity Acquisition Corporation425 - Longevity Acquisition Corp (0001743858) (Subject)
- SECSEC Form 425 filed by Longevity Acquisition Corporation425 - Longevity Acquisition Corp (0001743858) (Subject)
- PR4D Pharma to Present at Upcoming Investor Conferences in MarchLEEDS, England--(BUSINESS WIRE)--4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announced that 4D management will present at three upcoming investor conferences: Chardan's Virtual 3rd Annual Microbiome Medicines Summit: Monday March 8, 2021 at 11:45 am ET (16:45 GMT). H.C. Wainwright Global Life Sciences Conference: Available on-demand starting Tuesday, March 9, 2021 at 7:00 am ET (12:00 GMT). Oppenheimer’s 31st Annual Healthcare Conference: Tuesday, March 16, 2021 at 8:40 am ET (12:40 GMT). About 4D pharma Founded in February 2014, 4D pharma is a w
- PR4D Pharma Appoints John Beck as Chief Financial Officer and Member of the Management TeamLEEDS, England--(BUSINESS WIRE)--4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces the appointment of John Beck as Chief Financial Officer (CFO) and member of the Company’s management team, bringing over 30 years of experience in finance, including three previous positions as Chief Financial Officer of publicly traded life sciences companies. “John will be an important addition to 4D pharma’s management team at such a pivotal time, as the company prepares to close our SPAC merger and begin trading on NASDAQ. His deep experience and financial expert
- SECSEC Form 425 filed425 - Longevity Acquisition Corp (0001743858) (Subject)
- SECSEC Form 425 filed425 - Longevity Acquisition Corp (0001743858) (Subject)
- SECSEC Form 425 filed425 - Longevity Acquisition Corp (0001743858) (Subject)
- SECSEC Form 425 filed425 - Longevity Acquisition Corp (0001743858) (Subject)
- PR4D Pharma Announces U.S. SEC Declares Registration Statement Effective with Respect to the Issuance of 4D Pharma American Depositary Shares on NASDAQLEEDS, England--(BUSINESS WIRE)--4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces that the United States Securities and Exchange Commission (“SEC”) has declared effective its registration statements on Form F-4 with respect to the issuance of 4D pharma American Depositary Shares (“ADSs”) to the shareholders of Longevity Acquisition Corporation (NASDAQ: LOAC) (“Longevity”), a NASDAQ-listed special purpose acquisition company (“SPAC”), in connection with the previously announced merger between 4D pharma and Longevity. It is expected that 4D pharma ADS
- SECSEC Form PRER14A filedPRER14A - Longevity Acquisition Corp (0001743858) (Filer)
- SECSEC Form PRER14A filedPRER14A - Longevity Acquisition Corp (0001743858) (Filer)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Longevity Acquisition Corp (0001743858) (Subject)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Longevity Acquisition Corp (0001743858) (Subject)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Longevity Acquisition Corp (0001743858) (Subject)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Longevity Acquisition Corp (0001743858) (Subject)
- SECSEC Form 425 filed425 - Longevity Acquisition Corp (0001743858) (Subject)
LOAC FAQ
6 questionsWhat is the latest news on LOAC?
Quantisnow has not tracked any new filings, ratings or press releases for LOAC in the last 30 days. The most recent wire item was published on April 7, 2021.Where does LOAC stock trade?
Longevity Acquisition Corporation (LOAC) is listed on NASDAQ.What sector and industry is LOAC in?
Longevity Acquisition Corporation operates in the Finance sector, Business Services industry.When did Longevity Acquisition Corporation go public?
Longevity Acquisition Corporation (LOAC) completed its IPO in 2018.What companies are similar to LOAC?
Notable peers in the same industry include MA (Mastercard Incorporated), UBER (Uber Technologies Inc.), PDD (PDD Holdings Inc.), V (Visa Inc.), ACN (Accenture plc). Compare LOAC side-by-side with any of them on Quantisnow.How can I track LOAC on Quantisnow?
Quantisnow aggregates Longevity Acquisition Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow LOAC to receive live email and push alerts on every new disclosure.